Gastric Cancer
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 7, 2006; 12(25): 3965-3969
Published online Jul 7, 2006. doi: 10.3748/wjg.v12.i25.3965
Figure 1
Figure 1 Results of Shh RT-PCR. M: MarkerDL-2000; 1: Non-cancerous gastric tissues; 2: Well differentiated tubular adenocarcinoma; 3: Poorly differentiated tubular adenocarcinoma.
Figure 2
Figure 2 Results of Shh expression by in situ hybridization, blue represents positive. A: Non-cancerous gastric tissues (× 100); B: Well-moderately differentiated tubular adenocarcinoma (× 100); C: Poorly differentiated tubular adenocarcinoma (× 100); D: Papillary adenocarcinoma (× 100); E: Mucinous adenocarcinoma (× 200); F: Squamous cell carcinoma (× 100).
Figure 3
Figure 3 Results of Shh expression by immunohistochemistry (brown represents positive). A: Non-cancerous gastric tissues (× 100); B: Well-moderately differentiated tubular adenocarcinoma (× 100); C: Poorly differentiated adenocarcinoma (× 100); D: Papillary adenocarcinoma (× 100); E: Mucinous adenocarcinoma (× 200); F: Squamous cell carcinoma (× 100).
Figure 4
Figure 4 Results of Gli1 by in situ hybridization( blue represents positive). A: Non-cancerous stomach tissues (× 100); B: Moderately differentiated tubular adenocarcinoma (× 100); C: Poorly differentiated tubular adenocarcinoma (×100); D: Papillary adenocarcinoma (× 100); E: Mucinous adenocarcinoma (× 200); F: Squamous cell carcinoma (× 100).